Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acamprosate for Induced Alcohol Craving
NCT00605904Phase 2Completed
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism
- Start
- Jan 2008
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in alcohol dependence comparing Acamprosate with Placebo (2 arms). Primary endpoints: Alcohol Craving Rating in Response to Saline Infusion at 180 minutes, Alcohol Craving Rating in Response to Meta-Chlorophenylpiperazine at 180 minutes and 1 more. Started Jan 2008; status: completed.
02
Drugs
acamprosate
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00605904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00605904.